TrialThe Lancet. Neurology2025

Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case-control study.

Baayla D C Boon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.